• Nenhum resultado encontrado

[PDF] Top 20 Efficacy and safety of pegylated interferon plus ribavirin therapy for chronic hepatitis C genotype 6: a meta-analysis.

Has 10000 "Efficacy and safety of pegylated interferon plus ribavirin therapy for chronic hepatitis C genotype 6: a meta-analysis." found on our website. Below are the top 20 most common "Efficacy and safety of pegylated interferon plus ribavirin therapy for chronic hepatitis C genotype 6: a meta-analysis.".

Efficacy and safety of pegylated interferon plus ribavirin therapy for chronic hepatitis C genotype 6: a meta-analysis.

Efficacy and safety of pegylated interferon plus ribavirin therapy for chronic hepatitis C genotype 6: a meta-analysis.

... number of trials that met the inclusion criteria was ...designs, and only included three randomized controlled ...the efficacy of Peg-IFN and RBV may vary depending on the dose ... See full document

9

Tumour necrosis factor -308 and -238 promoter polymorphisms are predictors of a null virological response in the treatment of Brazilian hepatitis C patients

Tumour necrosis factor -308 and -238 promoter polymorphisms are predictors of a null virological response in the treatment of Brazilian hepatitis C patients

... likelihood of a sustained virological response (SVR) to treatment in subjects infected with hepatitis C virus ...promoters of interleukin (IL)-10 (-1082 A/G, rs1800896), myxovirus resistance ... See full document

7

Peginterferon alfa-2a (40KD) (PEGASYS®) plus ribavirin (COPEGUS®) in retreatment of chronic hepatitis C patients, nonresponders and relapsers to previous conventional interferon plus ribavirin therapy

Peginterferon alfa-2a (40KD) (PEGASYS®) plus ribavirin (COPEGUS®) in retreatment of chronic hepatitis C patients, nonresponders and relapsers to previous conventional interferon plus ribavirin therapy

... alfa plus ribavirin is currently the treatment of choice for chronic hepatitis ...(40KD) plus ribavirin has given an overall sustained virological response of 18% ... See full document

6

Psychosis during peginterferon-alpha2a and ribavirin therapy: case report

Psychosis during peginterferon-alpha2a and ribavirin therapy: case report

... with hepatitis C virus is an important public health problem and one of the most frequent chronic infectious diseases worldwide, with a global prevalence of 1%-2% ...[1]. ... See full document

2

Demographic and anthropometrical analysis and genotype distribution of chronic hepatitis C patients treated in public and private reference centers in Brazil

Demographic and anthropometrical analysis and genotype distribution of chronic hepatitis C patients treated in public and private reference centers in Brazil

... Hepatitis C virus (HCV) infection is a serious public health problem, since 80% to 85% of HCV carriers develop a persistent infection that can progress into liver cirrhosis and ...response ... See full document

8

Braz. J. Pharm. Sci.  vol.50 número2

Braz. J. Pharm. Sci. vol.50 número2

... with chronic hepatitis C (CHC) and genotype 2 or 3 is interferon alpha (IFN) plus ribavirin (RBV) for 24 ...aim of this study is compare the cost and ... See full document

8

Efficacy of combined antiviral therapy with pegylated interferon α-2a and ribavirin for chronic hepatitis C infection in intravenous drug users

Efficacy of combined antiviral therapy with pegylated interferon α-2a and ribavirin for chronic hepatitis C infection in intravenous drug users

... number of the patients in the group of IDUs had a problem with the abstinence of the drug ...influence of alcohol (30%) and other substances with potential hepatotoxicity: marihuana ... See full document

7

Chronic hepatitis C: hepatic iron content does not correlate with response to antiviral therapy

Chronic hepatitis C: hepatic iron content does not correlate with response to antiviral therapy

... biopsies and consisted of combined administration of standard interferon (3MU three times weekly) or peginterferon (α2b ...once-weekly) plus ribavirin (body weight < 75 kg: ... See full document

6

Assessment of the treatment of chronic hepatitis C in the state of Mato Grosso, central Brazil

Assessment of the treatment of chronic hepatitis C in the state of Mato Grosso, central Brazil

... treatment of hepatitis C virus (HCV) infection is funded by the national public health system ...state of Mato Grosso, central Brazil, we have consulted the files of the office ... See full document

7

Cost-effectiveness of antiviral therapy during late pregnancy to prevent perinatal transmission of hepatitis B virus

Cost-effectiveness of antiviral therapy during late pregnancy to prevent perinatal transmission of hepatitis B virus

... use of LdT and LAM is influenced by the RR of HBV ...the efficacy and cost of ...benefit of TDF when studies with large sample sizes show a 100% efficacy with LdT ... See full document

19

Neutralizing antibodies in patients with chronic hepatitis C, genotype 1, against a panel of genotype 1 culture viruses: lack of correlation to treatment outcome.

Neutralizing antibodies in patients with chronic hepatitis C, genotype 1, against a panel of genotype 1 culture viruses: lack of correlation to treatment outcome.

... DM110 and DM111 as described [11,35] and yielded amplicons for all individuals except ...AF009606)) of the 38 patients, the six included genotype 1 culture viruses, and culture viruses ... See full document

16

 Value in Health

Value in Health

... management of patients with chronic hepatitis C (CHC) owing to the difficulty of treatment with pegylated inter- feron/ribavirin ...ties of Peg-IFN/RBV ... See full document

1

Chronic Hepatitis C Treated with Peginterferon alfa plus Ribavirin in Clinical Practice

Chronic Hepatitis C Treated with Peginterferon alfa plus Ribavirin in Clinical Practice

... [r] ... See full document

7

Effect of sustained virologic response on the incidence of hepatocellular carcinoma in patients with HCV cirrhosis

Effect of sustained virologic response on the incidence of hepatocellular carcinoma in patients with HCV cirrhosis

... effect of SVR in re- ducing HCC occurrence in a group of HCV cirrhotic pa- tients treated with the combination of IFN plus RBV, indi- cating that the presence of the viral agent is ... See full document

5

Immunogenicity and acceptance of influenza A (H1N1) vaccine in a cohort of chronic hepatitis C patients receiving pegylated-interferon treatment.

Immunogenicity and acceptance of influenza A (H1N1) vaccine in a cohort of chronic hepatitis C patients receiving pegylated-interferon treatment.

... limitation of our study is the sample size which does not allow us to draw conclusions on vaccine efficacy or effectiveness based on percentage reduction of attack rates (number of new cases ... See full document

7

Lack of association of indoleamine 2,3-dioxygenase polymorphisms with interferon-alpha-related depression in hepatitis C

Lack of association of indoleamine 2,3-dioxygenase polymorphisms with interferon-alpha-related depression in hepatitis C

... set of 35 ancestry informative markers (AIMs), which exhibit a high level of allele frequency difference among the three founder populations of the Brazilian individuals (Europe- ans, West-Africans ... See full document

7

Rafaela Liz Pellegrim Sanchez-Lermen [5] , Izabelle Venturini Signorelli [6], Miguel Yasuo Tomita Nicacio [1] , Alberto Pereira Firmino Filho [1], Thais Guaraná de Andrade

Rafaela Liz Pellegrim Sanchez-Lermen [5] , Izabelle Venturini Signorelli [6], Miguel Yasuo Tomita Nicacio [1] , Alberto Pereira Firmino Filho [1], Thais Guaraná de Andrade

... stages of liver fibrosis (F3 or F4), but it was contraindicated for patients with decompensated cirrhosis (Child-Pugh B or C liver functional ...regardless of their degree of liver ...patients ... See full document

7

MATERIAL AND METHODS Patients

MATERIAL AND METHODS Patients

... No presente estudo, avaliamos a importância clínico- epidemiológica da genotipagem do VHC em 130 pacientes com diagnóstico histológico de hepatite crônica C e sua influência na resposta terapêutica sustentada. Não ... See full document

7

Response predictors to treatment with pegylated interferon in chronic hepatitis B

Response predictors to treatment with pegylated interferon in chronic hepatitis B

... absence of viral resistance, which allows other treatment options if there is no initial ...This therapy is better indicated for patients with a high chance of re- sponse, as poor responders could be ... See full document

7

Cryoglobulinemia in chronic hepatitis C: clinical aspects and response to treatment with interferon alpha and ribavirin

Cryoglobulinemia in chronic hepatitis C: clinical aspects and response to treatment with interferon alpha and ribavirin

... (78% of the patients). Major signs and symptoms related to the presence of cryoglobulin occurred in 24% of the positive subjects, resulting in a 6% overall prevalence of ... See full document

6

Show all 10000 documents...